Updated September 2026Four weeks, not a monthSpry review
Two GLP-1 rates on the front page, billed on a four-week cycle the cards never mention.
The verdict
Spry publishes $199 for semaglutide and $299 for tirzepatide with no contract. Its FAQ describes re-billing every four weeks, which is thirteen charges a year rather than twelve.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- From
- From $199/mo
- Dose published
- No
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Pharmacy
- Not named
Spry sells five injectables from one screen: semaglutide and tirzepatide under weight loss, and BPC-157, NAD+ and sermorelin under anti-aging. Every figure is on the homepage before any intake. The catalog is small and the pages are short.
Who writes the prescription, and what do they see?
A nurse practitioner reviews each file within twenty-four hours, and Spry says medication is ordered and shipped once that review approves it. Three co-founders are pictured by name. None carries a credential beside the name, and the team is described collectively as medical professionals with more than twenty years of experience. No medical director is identified.
Nurses and staff are described as reaching out consistently to check on targets, with support hours of nine to five Eastern on weekdays. There are no contracts or commitment requirements. Insurance is not accepted, though Spry will supply a document for a patient to submit for reimbursement, and HSA plans often qualify.
What happens when the dose goes up?
Spry says it works to titrate the dose to the level that suits the patient and that most side effects can be managed with over-the-counter medication. The billing cycle is built around the climb: a vial covers four weekly injections, then the next one ships. No milligram is published and nothing states whether the charge moves as the dose rises.
What the price includes
The cards read $199 and $299. The FAQ explains what those figures buy: four weeks of medication, after which Spry re-bills and ships the next vial. Thirteen four-week cycles fall in a year, so the semaglutide rate works out at $215.58 a calendar month and tirzepatide at $323.92. That conversion is arithmetic on Spry's two published numbers, not a figure Spry prints.
What it claims, and what it cites
Both GLP-1 lines are compounded, so neither is FDA-approved and neither is reviewed by the FDA before dispensing. The compounding pharmacy is not named. Spry's FAQ also states that oral versions of these medications simply do not work as well as weekly injections, a comparative claim it attaches to no study.
Where it holds up, and where it does not
- Strength: Both GLP-1 rates on the homepage, before any intake
- Strength: Review promised within twenty-four hours
- Strength: No contract and no commitment requirement
- Strength: Reimbursement paperwork offered for insurance claims
- Limitation: The four-week cycle is in the FAQ, not on the price card
- Limitation: Thirteen charges a year, not twelve
- Limitation: No credential is attached to any named founder
- Limitation: A comparative claim about oral GLP-1s carries no source
- Limitation: No milligram and no compounding pharmacy is published
What the evidence says about this kind of treatment
The assessment above is about Spry. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A buyer who reads the billing cycle before comparing a price against a monthly one.
- Wrong for
- A buyer budgeting twelve payments a year against another seller's monthly rate.
How Spry compares
| Seller | Who it suits | Go |
|---|---|---|
 LumiMeds | Buyers who want the ingredient, route and pharmacy type labeled before they pay | See LumiMeds → |
 Nova MD | Buyers who will read which plan is already selected before they press start | See Nova MD → |
 Omzo | Buyers who want the medication cost inside one fee rather than billed by a pharmacy | See Omzo → |
More GLP-1 telehealth sellers reviews: TryoziTuyo HealthVaylenVevaRXVigorMedsVirtualCare2Go
Sponsored alternative
Bodybuilding Health+
A reader unwilling to prepay a year before seeing how the drug goes
Check Bodybuilding Health+ availability →Frequently asked
- Is $199 a monthly charge?
- No. Spry's FAQ describes four weekly injections, then a re-bill and the next vial, which is a four-week cycle.
- How many charges fall in a year?
- Thirteen, on a four-week cycle. Twelve monthly charges at $199 would be a different total.
- Who reviews the intake?
- Spry states a nurse practitioner reviews each file within twenty-four hours before medication is ordered.
- Is Spry expensive compared with other GLP-1 telehealth sellers?
- Spry publishes a starting figure of $199/mo. Across the 252 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $399 with a median of $178, which puts Spry above the median. The other 19 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.